Financial Performance - Operating revenue for the first nine months was CNY 515,686,202.47, a decline of 27.84% year-on-year[7] - Net profit attributable to shareholders was CNY -179,010,428.59, representing a decrease of 26.31% compared to the same period last year[8] - Basic earnings per share decreased by 34.75% to CNY -0.7026[8] - Total operating revenue for the first nine months of 2015 was ¥515,686,202.47, down 27.8% from ¥714,620,034.31 in the same period of 2014[29] - Net loss for the first nine months of 2015 was ¥265,638,227.76, compared to a net loss of ¥209,167,902.52 in the same period of 2014, reflecting a worsening of 27.0%[30] - Total operating revenue for Q3 2015 was ¥167,250,303.47, a decrease of 40.0% compared to ¥279,155,527.61 in Q3 2014[29] - Net loss for Q3 2015 was ¥81,935,114.08, compared to a net loss of ¥131,694,882.88 in Q3 2014, showing an improvement of 37.7%[30] - The gross profit margin for Q3 2015 was -49.3%, compared to -48.5% in Q3 2014, indicating a decline in profitability[30] Cash Flow and Liquidity - Cash flow from operating activities increased by 39.00% to CNY 134,979,672.83 for the first nine months[7] - Cash flow from operating activities for the first nine months of 2015 was CNY 134,979,672.83, an increase from CNY 97,105,640.31 in the previous year[37] - Cash flow from investing activities showed a net outflow of CNY 12,263,311.83 for the first nine months of 2015, compared to a net outflow of CNY 29,129,097.97 in the same period last year[37] - Cash flow from financing activities resulted in a net outflow of CNY 230,020,640.35 in Q3 2015, contrasting with a net inflow of CNY 20,280,364.11 in the previous year[38] - The ending balance of cash and cash equivalents is CNY 60.03 million, a decrease of CNY 92.30 million or 60.59% compared to the end of the previous year, primarily due to repayment of bank loans[14] - The cash and cash equivalents at the end of Q3 2015 were CNY 27,141,317.98, a significant decrease from CNY 210,751,617.84 at the end of the previous year[38] - The ending balance of cash and cash equivalents was CNY 2,626,039.08, a significant decrease from CNY 95,386,291.96 at the end of the previous year[41] Assets and Liabilities - Total assets decreased by 4.34% to CNY 3,984,946,644.69 compared to the end of the previous year[7] - Total liabilities increased to ¥3,253,343,501.39 from ¥3,168,464,861.23, representing a growth of approximately 2.68%[22] - Current liabilities totaled ¥2,553,795,677.13, up from ¥2,486,425,748.89, indicating an increase of about 2.71%[22] - Non-current liabilities amounted to ¥699,547,824.26, compared to ¥682,039,112.34, reflecting a rise of approximately 2.36%[22] - Total equity attributable to shareholders decreased to ¥568,052,834.36 from ¥739,133,948.89, a decline of approximately 23.1%[22] Shareholder Information - The total number of shareholders reached 13,276 by the end of the reporting period[11] - The largest shareholder, Xinjiang Production and Construction Corps, holds 47.07% of the shares[11] Operational Developments - The company has not disclosed any new product developments or market expansion strategies in this report[6] - The company established Baihua Village (Tianjin) International Trade Company with a registered capital of CNY 5 million, holding a 51% stake, which is included in the consolidated financial statements[16] Employee Compensation - The ending balance of employee compensation payable is CNY 81.96 million, an increase of CNY 42.93 million or 110.00% compared to the end of the previous year, mainly due to increased employee wages and social insurance[14]
百花医药(600721) - 2015 Q3 - 季度财报